Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
US7262286B2 · kind B2 · utility
29Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2001 |
| Grant date | Aug 28, 2007 |
| Priority date | — |
| Expiry date | Dec 13, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/336
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the therapeutic use of oligonucleotides or oligonucleotide analogs as immunostimulatory agents in immunotherapy applications. The invention provides methods for enhancing the immune response caused by immunostimulatory oligonucleotide compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.